Cadrenal Therapeutics appoints John P. Sharp interim CFO; board member resigns, classes realigned

Cadrenal Therapeutics, Inc.

John P. Sharp appointed Interim CFO effective June 25, 2026, replacing Quang X. Pham.
Compensation: $455/hour, up to 24 hours/week via Lohman & Associates Master Services Agreement.
Steven Zelenkofske resigns from board effective June 30, 2026; no disagreement cited.
Board realigned: Glynn Wilson moved from Class I to Class III director to balance classes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.